Skip to main content
NCBI home page
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1976 Jan 10;114(1):43–44.

Control of recurrent supraventricular tachycardia with amiodarone hydrochloride.

J H Swan, A W Chisholm
PMCID: PMC1956563  PMID: 943223

Abstract

Amiodarone hydrochloride, a new antiarrhythmic agent, controlled a recurrent supraventricular arrhythmia, refractory to conventional medical treatment, in a 57-year-old patient with an anomalous conduction system and idiopathic cardiomyopathy. For the 11 months that the patient has been taking the drug her arrhythmia has not recurred. This drug has produced no important side effects in this patient.

Full text

PDF
43

Images in this article

43FIG. 1
on p.43
44FIG. 2
on p.44

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Babel J., Stangos N. L'action de l'amiodarone sur les tissus oculaires. Schweiz Med Wochenschr. 1972 Feb 19;102(7):220–223. [PubMed] [Google Scholar]
  2. Baudine A., Chaillet F., Charlier R., Hosslet A. Recherches dans la série des benzofurannes. XXVI. Effets pharmacologiques généraux de l'amiodarone. Arch Int Pharmacodyn Ther. 1967 Oct;169(2):469–481. [PubMed] [Google Scholar]
  3. Charlier R., Deltour G., Baudine A., Chaillet F. Pharmacology of amiodarone, and anti-anginal drug with a new biological profile. Arzneimittelforschung. 1968 Nov;18(11):1408–1417. [PubMed] [Google Scholar]
  4. Delage C., Lagacé R., Huard J. Pseudocyanotic pigmentation of the skin induced by amiodarone: a light and electron microscopic study. Can Med Assoc J. 1975 May 17;112(10):1205–1208. [PMC free article] [PubMed] [Google Scholar]
  5. Hazard J., Perlemuter L., Bernheim R., Guilhaume B., Richier D. Insuffisances thyroïdiennes secondaires à un traitement par l'amiodarone. 2 nouvelles observations. Nouv Presse Med. 1973 Mar 17;2(11):691–693. [PubMed] [Google Scholar]
  6. Olsson S. B., Brorson L., Varnauskas E. Class 3 antiarrhythmic action in man. Observations from monophasic action potential recordings and amiodarone treatment. Br Heart J. 1973 Dec;35(12):1255–1259. doi: 10.1136/hrt.35.12.1255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Petta J. M., Zaccheo V. J. Comparative profile of L 3428 and other antianginal agents on cardiac hemodynamics. J Pharmacol Exp Ther. 1971 Feb;176(2):328–338. [PubMed] [Google Scholar]
  8. Rosenbaum M. B., Chiale P. A., Ryba D., Elizari M. V. Control of tachyarrhythmias associated with Wolff-Parkinson-White syndrome by amiodarone hydrochloride. Am J Cardiol. 1974 Aug;34(2):215–223. doi: 10.1016/0002-9149(74)90200-8. [DOI] [PubMed] [Google Scholar]
  9. Singh B. N., Hauswirth O. Comparative mechanisms of action of antiarrhythmic drugs. Am Heart J. 1974 Mar;87(3):367–382. doi: 10.1016/0002-8703(74)90080-5. [DOI] [PubMed] [Google Scholar]
  10. Singh B. N., Vaughan Williams E. M. The effect of amiodarone, a new anti-anginal drug, on cardiac muscle. Br J Pharmacol. 1970 Aug;39(4):657–667. doi: 10.1111/j.1476-5381.1970.tb09891.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES